~32,000 sq. ft. EU-GMP Designed Cannabis & Pharmaceutical Processing Facility for Sale in Germany

~32,000 sq. ft. (~3,000 m²) facility located within a medical campus in Lower Saxony, Germany.

Purpose-built GMP layout, designed for pharmaceutical and commercial production including extraction, tolling, formulation, bulk oils/distillates, tinctures, capsules, functional edibles, cosmetics, vapes, and pre-rolls.

Building shell approximately 80% complete, with cleanroom fit-outs advanced and remaining laboratory infrastructure, equipment installation, and utility integration progressing toward completion.

Advanced processing infrastructure includes a Devex cryogenic extraction system (€1.2M value; 3,200 kg/month throughput capacity), VTA short-path distillation system, GEA Niro Soavi homogenizer, and Interchem HPLC chromatography system.

Detailed engineering designs completed, with approximately €4.59M remaining CAPEX required over an estimated 12-month timeline to reach operational commissioning.

Facility infrastructure includes 750 kW electrical service, municipal water supply, and natural gas capabilities designed to support operations.

Experienced in-house QP and technical team in place, expected to remain post-transaction to support the 9–10 month EU-GMP certification process following commissioning.

~€7.0M–€7.4M invested in facility build-out and equipment, with the property valued at approximately €3.6M.

Tax-clean corporate structure with no outstanding liabilities, with existing mortgage capable of being discharged at closing or assumed by the buyer subject to lender approval.

Expansion opportunity available through acquisition of adjacent commercial development land.

100% acquisition of share capital across both operating company and real estate entity, providing full ownership of the licences, business, and facility for €5,000,000.